Target intelligence / Profile preview

RNA, U6 small nuclear 530, pseudogene (RNU6-530P)

Target
RNU6-530P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 530, pseudogene (RNU6-530P) is a non-protein-coding derivative of the U6 small nuclear RNA gene that has accumulated mutations or sequence changes preventing it from producing functional U6 snRNA[1][5]. U6 snRNA itself is a highly conserved non-coding component of spliceosomal small nuclear ribonucleoproteins (snRNPs) essential for pre-mRNA splicing within the eukaryotic nucleus[5]. However, pseudogene copies like RNU6-530P are generally not expressed as functional snRNAs and are not involved in catalysis of splicing or other recognized molecular processes. Although some pseudogenes can influence gene regulation by acting as miRNA sponges or through competing endogenous RNA effects[4], there is no published evidence of RNU6-530P having such activity or relevance in disease. Key points: - This entry is for a pseudogene—not a protein, receptor, enzyme, or classical drug target. - U6 snRNA pseudogenes are common and reflect the evolutionary importance of the U6 gene[5]. - Most pseudogenes are nonfunctional, though some may have regulatory roles at the RNA level[4]. - No drugs, biomarkers, or safety concerns are reported for RNU6-530P.

Other names
RNU6-530P
02

Biological functions

May participate in competing endogenous RNA (ceRNA) or miRNA sponge mechanisms (general to pseudogenes)[4]No direct evidence of functional involvement or activity for RNU6-530P specifically
03

Disease associations

Other (general pseudogenes may be dysregulated in diseases such as cancer, but no data for RNU6-530P)[4]

Beyond the preview

Go deeper on RNA, U6 small nuclear 530, pseudogene (RNU6-530P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 530, pseudogene (RNU6-530P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call